Arcadia Biosciences(RKDA) - 2023 Q4 - Annual Results

1 Arcadia Biosciences, Inc. Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (In thousands, except share data and per share data) | | | | Year Ended December 31, | | | --- | --- | --- | --- | --- | | | | 2023 | | 2022 | | Revenues: | | | | | | Product | $ | 5,313 | $ | 6,422 | | License | | 17 | | 879 | | Royalty | | — | | — | | Total revenues | | 5,330 | | 7,301 | | Operating expenses (income): | | | | | | Cost of revenues | | 3,300 | | 6,101 | | Research and development | | 1,387 | ...